1 |
(2)-epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
008 1件: 8 💬 |
2 |
Capsules with 160 mg teavigo (at least 94% egcg) |
Epigallocatechin gallate |
- |
- |
- |
013 1件: 13 💬 |
3 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus egcg |
Amiodarone |
2件: D00636 D00636, D02910 D02910 💬 |
ADRA1A 16件: ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 31件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 1件: 28 💬 |
4 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
5 |
Egcg + tocotrienol |
Epigallocatechin gallate |
- |
- |
- |
299 1件: 299 💬 |
6 |
Egcg as putative neuroprotective agent |
Epigallocatechin gallate |
- |
- |
- |
017 1件: 17 💬 |
7 |
Egcg fontup |
Epigallocatechin gallate |
- |
- |
- |
206 1件: 206 💬 |
8 |
Epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
028 2件: 28, 85 💬 |
9 |
Green tea polyphenols (egcg/ecg) |
Epigallocatechin gallate |
1件: D06903 D06903 💬 |
- |
- |
006 1件: 6 💬 |
10 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
013 3件: 13, 17, 113 💬 |
11 |
Sunphenon egcg tm |
- |
- |
- |
- |
013 1件: 13 💬 |